Basel, Switzerland

Marianne Manchester Young

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marianne Manchester Young. Retrieved from https://idiyas.com/inventor/marianne-manchester-young

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marianne Manchester Young: Innovator in Therapeutic Solutions

Introduction

Marianne Manchester Young is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of therapeutics, particularly in the development of methods to enhance treatment efficacy.

Latest Patents

Marianne holds a patent for the "Use of a cathepsin S inhibitor against the formation of anti-drug antibodies." This invention focuses on utilizing a cathepsin S inhibitor to reduce or prevent the formation of anti-drug antibodies (ADA) in subjects undergoing treatment with therapeutic agents. Her innovative approach aims to improve patient outcomes by addressing a common challenge in drug therapy.

Career Highlights

Marianne is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. Her work there has been instrumental in advancing therapeutic strategies and enhancing the effectiveness of treatments.

Collaborations

She has collaborated with esteemed colleagues, including Christian Klein and Fabrice Alain Andre Kolb, contributing to a dynamic research environment that fosters innovation.

Conclusion

Marianne Manchester Young's contributions to the field of therapeutics exemplify her commitment to improving patient care through innovative solutions. Her work continues to inspire advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…